Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
August-2014 Volume 8 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2014 Volume 8 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

IRGM rs13361189 polymorphism may contribute to susceptibility to Crohn's disease: A meta-analysis

  • Authors:
    • Yao Lu
    • Chun-Yu Li
    • Shu-Sen Lin
    • Peng Yuan
  • View Affiliations / Copyright

    Affiliations: Department of Anorectal, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning 110032, P.R. China
  • Pages: 607-613
    |
    Published online on: May 28, 2014
       https://doi.org/10.3892/etm.2014.1736
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present meta‑analysis was to evaluate the correlation between a common polymorphism, rs13361189 C>T in the immunity‑related GTPase M (IRGM) gene, and susceptibility to Crohn's disease (CD). The PubMed, CISCOM, CINAHL, Web of Science, Google Scholar, EBSCO, Cochrane Library and CBM databases were investigated from database inception through to October 1, 2013 without the application of any language restrictions. The meta‑analysis was performed using STATA 12.0 software and the relative risk (RR) with a 95% confidence interval (CI) was calculated. Seven case‑control studies were included with a total of 3,093 CD patients and 3,227 healthy control subjects. The results of the meta‑analysis revealed that the IRGM rs13361189 polymorphism correlates with an increased risk of CD (T allele versus C allele: RR=1.25 with 95% CI, 1.04‑1.50; P=0.016 and CT + TT versus CC: RR=1.21 with 95% CI, 1.03‑1.42; P=0.018). A subgroup analysis conducted using a genotyping method indicated that the IRGM rs13361189 polymorphism was correlated with an increased risk of CD in the TaqMan® (T allele versus C allele: RR=1.32 with 95% CI, 1.01‑1.73; P=0.042) and the polymerase chain reaction‑restriction fragment length polymorphism subgroups (T allele versus C allele: RR=1.80 with 95% CI, 1.32‑2.45; P<0.001 and CT + TT versus CC: RR=1.61 with 95% CI, 1.19‑2.18; P=0.018). However, no correlation was observed in the direct sequencing subgroup (P>0.05). Further subgroup analysis by sample size demonstrated significant correlations between the IRGM rs13361189 polymorphism and an increased risk of CD in the large sample‑size subgroup (T allele versus C allele: RR=1.46 with 95% CI, 1.26‑1.68; P<0.001 and CT + TT versus CC: RR=1.40 with 95% CI, 1.21‑1.62; P<0.001). However, no correlation was identified between the IRGM rs13361189 polymorphism and CD risk in the small sample‑size subgroup (P>0.05). The present meta‑analysis indicated that the IRGM rs13361189 polymorphism may contribute to susceptibility to CD. Thus, IRGM rs13361189 polymorphism may be a potential biomarker for the early diagnosis of CD.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Frank DN, Robertson CE, Hamm CM, et al: Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis. 17:179–184. 2011. View Article : Google Scholar : PubMed/NCBI

2 

Zheng JJ, Shi XH, Zhu XS, et al: A comparative study of incidence and prevalence of Crohn’s disease in mainland China in different periods. Zhonghua Nei Ke Za Zhi. 50:597–600. 2011.(In Chinese).

3 

Prescott NJ, Dominy KM, Kubo M, et al: Independent and population-specific association of risk variants at the IRGM locus with Crohn’s disease. Hum Mol Genet. 19:1828–1839. 2010.PubMed/NCBI

4 

Sivaram G, Tiwari SK, Bardia A, et al: Macrophage migration inhibitory factor, Toll-like receptor 4, and CD14 polymorphisms with altered expression levels in patients with ulcerative colitis. Hum Immunol. 73:201–205. 2012. View Article : Google Scholar : PubMed/NCBI

5 

Joossens M, Van Steen K, Branche J, et al: Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohn’s disease. Inflamm Bowel Dis. 16:58–67. 2010.PubMed/NCBI

6 

Brest P, Lapaquette P, Mograbi B, et al: Risk predisposition for Crohn disease: a ‘ménage à trois’ combining IRGM allele, miRNA and xenophagy. Autophagy. 7:786–787. 2011.

7 

Glas J, Seiderer J, Bues S, et al: IRGM variants and susceptibility to inflammatory bowel disease in the German population. PLoS One. 8:e543382013. View Article : Google Scholar : PubMed/NCBI

8 

Taylor GA: IRG proteins: key mediators of interferon-regulated host resistance to intracellular pathogens. Cell Microbiol. 9:1099–1107. 2007. View Article : Google Scholar : PubMed/NCBI

9 

Moon CM, Shin DJ, Kim SW, et al: Associations between genetic variants in the IRGM gene and inflammatory bowel diseases in the Korean population. Inflamm Bowel Dis. 19:106–114. 2013. View Article : Google Scholar : PubMed/NCBI

10 

Nord H: Application of genomic and expression arrays for identification of new cancer genes. Dissertation. Uppsala University. Acta Universitatis Upsaliensis; ISSN: 1651-6206Uppsala, Sweden: 2010

11 

Mizushima N, Levine B, Cuervo AM and Klionsky DJ: Autophagy fights disease through cellular self-digestion. Nature. 451:1069–1075. 2008. View Article : Google Scholar : PubMed/NCBI

12 

Strausberg RL, Feingold EA, Grouse LH, et al; Mammalian Gene Collection Program Team. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci U S A. 99:16899–16903. 2002. View Article : Google Scholar : PubMed/NCBI

13 

Deretic V: Autophagy, an immunologic magic bullet: Mycobacterium tuberculosis phagosome maturation block and how to bypass it. Future Microbiol. 3:517–524. 2008. View Article : Google Scholar : PubMed/NCBI

14 

Eskelinen EL and Saftig P: Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim Biophys Acta. 1793:664–673. 2009. View Article : Google Scholar : PubMed/NCBI

15 

Xavier RJ, Huett A and Rioux JD: Autophagy as an important process in gut homeostasis and Crohn’s disease pathogenesis. Gut. 57:717–720. 2008.PubMed/NCBI

16 

Palomino-Morales RJ, Oliver J, Gómez-García M, et al: Association of ATG16L1 and IRGM genes polymorphisms with inflammatory bowel disease: a meta-analysis approach. Genes Immun. 10:356–364. 2009. View Article : Google Scholar : PubMed/NCBI

17 

Roberts RL, Hollis-Moffatt JE, Gearry RB, et al: Confirmation of association of IRGM and NCF4 with ileal Crohn’s disease in a population-based cohort. Genes Immun. 9:561–565. 2008.PubMed/NCBI

18 

Wolfkamp SC, Te Velde AA, Weersma RK, et al: Is there a role for Crohn’s disease-associated autophagy genes ATG16L1 and IRGM in formation of granulomas? Eur J Gastroenterol Hepatol. 22:933–937. 2010.

19 

Zheng LM and Pang Z: Association of IRGM and ATG16L1 gene polymorphisms with Crohn’s disease in the Chinese Han population. Chin J Gastroenterol Hepatol. 21:437–440. 2012.(In Chinese).

20 

Meggyesi N, Kiss LS, Koszarska M, et al: NKX2–3 and IRGM variants are associated with disease susceptibility to IBD in Eastern European patients. World J Gastroenterol. 16:5233–5240. 2010.

21 

Stang A: Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 25:603–605. 2010. View Article : Google Scholar : PubMed/NCBI

22 

Dupont WD and Plummer WD Jr: Power and sample size calculations. A review and computer program. Control Clin Trials. 11:116–128. 1990. View Article : Google Scholar : PubMed/NCBI

23 

Zintzaras E and Ioannidis JP: HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics. 21:3672–3673. 2005. View Article : Google Scholar : PubMed/NCBI

24 

Peters JL, Sutton AJ, Jones DR, et al: Comparison of two methods to detect publication bias in meta-analysis. JAMA. 295:676–680. 2006. View Article : Google Scholar : PubMed/NCBI

25 

Durães C, Machado JC, Portela F, et al: Phenotype-genotype profiles in Crohn’s disease predicted by genetic markers in autophagy-related genes (GOIA study II). Inflamm Bowel Dis. 19:230–239. 2013.PubMed/NCBI

26 

Prager M, Büttner J, Haas V, et al: The JAK2 variant rs10758669 in Crohn’s disease: altering the intestinal barrier as one mechanism of action. Int J Colorectal Dis. 27:565–573. 2012.

27 

Wang MH, Okazaki T, Kugathasan S, et al: Contribution of higher risk genes and European admixture to Crohn’s disease in African Americans. Inflamm Bowel Dis. 18:2277–2287. 2012.PubMed/NCBI

28 

Deretic V: Autophagy as an innate immunity paradigm: expanding the scope and repertoire of pattern recognition receptors. Curr Opin Immunol. 24:21–31. 2012. View Article : Google Scholar : PubMed/NCBI

29 

Folmes CD, Dzeja PP, Nelson TJ and Terzic A: Metabolic plasticity in stem cell homeostasis and differentiation. Cell Stem Cell. 11:596–606. 2012. View Article : Google Scholar : PubMed/NCBI

30 

He C and Klionsky DJ: Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet. 43:67–93. 2009. View Article : Google Scholar : PubMed/NCBI

31 

Caramés B, Taniguchi N, Otsuki S, et al: Autophagy is a protective mechanism in normal cartilage, and its aging-related loss is linked with cell death and osteoarthritis. Arthritis Rheum. 62:791–801. 2010.PubMed/NCBI

32 

Deretic V, Saitoh T and Akira S: Autophagy in infection, inflammation and immunity. Nat Rev Immunol. 13:722–737. 2013. View Article : Google Scholar : PubMed/NCBI

33 

McCarroll SA, Huett A, Kuballa P, et al: Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn’s disease. Nat Genet. 40:1107–1112. 2008.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Lu Y, Li C, Lin S and Yuan P: IRGM rs13361189 polymorphism may contribute to susceptibility to Crohn's disease: A meta-analysis. Exp Ther Med 8: 607-613, 2014.
APA
Lu, Y., Li, C., Lin, S., & Yuan, P. (2014). IRGM rs13361189 polymorphism may contribute to susceptibility to Crohn's disease: A meta-analysis. Experimental and Therapeutic Medicine, 8, 607-613. https://doi.org/10.3892/etm.2014.1736
MLA
Lu, Y., Li, C., Lin, S., Yuan, P."IRGM rs13361189 polymorphism may contribute to susceptibility to Crohn's disease: A meta-analysis". Experimental and Therapeutic Medicine 8.2 (2014): 607-613.
Chicago
Lu, Y., Li, C., Lin, S., Yuan, P."IRGM rs13361189 polymorphism may contribute to susceptibility to Crohn's disease: A meta-analysis". Experimental and Therapeutic Medicine 8, no. 2 (2014): 607-613. https://doi.org/10.3892/etm.2014.1736
Copy and paste a formatted citation
x
Spandidos Publications style
Lu Y, Li C, Lin S and Yuan P: IRGM rs13361189 polymorphism may contribute to susceptibility to Crohn's disease: A meta-analysis. Exp Ther Med 8: 607-613, 2014.
APA
Lu, Y., Li, C., Lin, S., & Yuan, P. (2014). IRGM rs13361189 polymorphism may contribute to susceptibility to Crohn's disease: A meta-analysis. Experimental and Therapeutic Medicine, 8, 607-613. https://doi.org/10.3892/etm.2014.1736
MLA
Lu, Y., Li, C., Lin, S., Yuan, P."IRGM rs13361189 polymorphism may contribute to susceptibility to Crohn's disease: A meta-analysis". Experimental and Therapeutic Medicine 8.2 (2014): 607-613.
Chicago
Lu, Y., Li, C., Lin, S., Yuan, P."IRGM rs13361189 polymorphism may contribute to susceptibility to Crohn's disease: A meta-analysis". Experimental and Therapeutic Medicine 8, no. 2 (2014): 607-613. https://doi.org/10.3892/etm.2014.1736
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team